We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
KBR
KBR
$4.56B
| $3.34M | 0.03% |
149,242
-1,766
| -1% | -$41K |
|
427
Avient
AVNT
$3.29B
| $3.34M | 0.03% |
126,072
+5,458
| +5% | +$142K |
|
|
BFX
428
DELISTED
BowFlex Inc.
BFX
| $3.31M | 0.03% |
192,659
-212,845
| -52% | -$2.73M |
|
429
Devon Energy
DVN
$51.3B
| $3.29M | 0.03% |
+347,770
| New | +$3.66M |
|
430
Inspire Medical Systems
INSP
$1.47B
| $3.28M | 0.03% |
25,392
-2,698
| -10% | -$297K |
|
|
LDL
431
DELISTED
Lydall, Inc.
LDL
| $3.19M | 0.03% |
192,814
+1,464
| +0.8% | +$25.5K |
|
432
Prothena Corp
PRTA
$448M
| $3.18M | 0.03% |
318,304
-14,615
| -4% | -$176K |
|
433
REX American Resources
REX
$1.39B
| $3.17M | 0.03% |
289,506
-111,174
| -28% | -$1.26M |
|
|
AGS
434
DELISTED
PlayAGS
AGS
| $3.16M | 0.03% |
892,678
-52,262
| -6% | -$196K |
|
|
PENG
435
Penguin Solutions Inc
PENG
$2.24B
| $3.12M | 0.03% |
228,304
-10,934
| -5% | -$146K |
|
436
Wyndham Hotels & Resorts
WH
$5.61B
| $3.12M | 0.03% |
61,707
-9,595
| -13% | -$469K |
|
437
Preferred Bank
PFBC
$1.24B
| $3.08M | 0.03% |
95,725
-3,475
| -4% | -$130K |
|
438
Asbury Automotive
ABG
$4.62B
| $3.07M | 0.03% |
+31,546
| New | +$3.19M |
|
439
Amphastar Pharmaceuticals
AMPH
$907M
| $3.06M | 0.03% |
162,927
-10,645
| -6% | -$214K |
|
440
Freshpet
FRPT
$3.04B
| $3.05M | 0.03% |
27,339
-557
| -2% | -$56.7K |
|
441
Neurocrine Biosciences
NBIX
$18.2B
| $3.03M | 0.03% |
31,481
+3,947
| +14% | +$457K |
|
442
Bread Financial
BFH
$4.32B
| $3.02M | 0.03% |
90,083
-20,140
| -18% | -$716K |
|
443
American International
AIG
$42.5B
| $3.01M | 0.03% |
109,424
-71,583
| -40% | -$2.13M |
|
444
Upwork
UPWK
$1.18B
| $2.94M | 0.03% |
168,460
+10,878
| +7% | +$163K |
|
445
Rapid7
RPD
$628M
| $2.93M | 0.03% |
47,865
-6,498
| -12% | -$386K |
|
446
Omnicom Group
OMC
$22.7B
| $2.92M | 0.03% |
58,907
-351,972
| -86% | -$18.8M |
|
447
Banner Corp
BANR
$2.38B
| $2.9M | 0.03% |
90,057
-24,999
| -22% | -$880K |
|
448
Intel
INTC
$413B
| $2.88M | 0.03% |
55,551
+51,990
| +1,460% | +$2.7M |
|
449
Spotify
SPOT
$108B
| $2.86M | 0.03% |
11,806
-4,214
| -26% | -$1.09M |
|
450
Unisys
UIS
$252M
| $2.86M | 0.03% |
268,225
+26,146
| +11% | +$300K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.